---
figid: PMC8564564__gr4
figtitle: Unfolding the role of autophagy in the cancer metabolism
organisms:
- NA
pmcid: PMC8564564
filename: gr4.jpg
figlink: /pmc/articles/PMC8564564/figure/fig4/
number: F4
caption: Autophagy participating in tumor progression and tumor inhibition. 1. Autophagy
  nurtures tumor progression by providing ATP to tumor cells. a. Autophagy directs
  glycolysis for ATP production. b. However, if glycolysis is not fully completed,
  it can be diverted to either glutaminolysis or pyruvate, and both can converge to
  the TCA cycle. c. Pyruvate can also be diverted to lactate and H+ production in
  anaerobic conditions or acetyl CoA production in aerobic conditions. Further, acetyl
  CoA can either be directly involved in the TCA cycle or undergo Free fatty acids
  (FFA) production. d. FFA is simplified by entering β-oxidation and eventually converges
  to the TCA cycle. e. The activated TCA cycle with provided raw materials from different
  stages of metabolic pathways produces NADH and ATP, which fuels oxidative phosphorylation
  and gives rise to ATP production. f. The complex macromolecules are recycled by
  autophagy and produce ATPs. 2. Autophagy inhibits tumor progression. a. JNK1 phosphorylates
  and deactivates Bcl-2, whereas DAPK phosphorylates and activates BECN1, thereby
  disrupting the Bcl-2-BECN1 complex and releases BECN1. b. p53 upregulating either
  UVRAG or Bif-1 that form multiprotein complex BECN1. c. the activated BECN1 further
  complexes with VPS-34 and promotes autophagosome formation. d. p53 subcellular localization
  gives contrasting results as p53 inside the nucleus activates AMPK promoting autophagy
  whereas in cytoplasm promotes mTOR, which inhibits autophagy.e. Autophagy promotes
  tumor inhibition by preventing p62 (SQSTM1) accumulation, DNA damage and activating
  the pentose phosphate pathway. NADPH activates the enzymes glutathione and impedes
  ROS production. (Abbreviations- FFA-Free fatty acids, JNK1- c Jun N Terminal Kinase,
  DAPK-Death Associated Protein Kinase, UVRAG-UV radiation resistance-associated gene,
  Bif-1-Bax-interacting factor-1, AMPK- AMP-Activated Protein Kinase, the mTOR-mechanistic
  target of rapamycin).
papertitle: Unfolding the role of autophagy in the cancer metabolism.
reftext: Anchala Pandey, et al. Biochem Biophys Rep. 2021 Dec;28:101158.
year: '2021'
doi: 10.1016/j.bbrep.2021.101158
journal_title: Biochemistry and Biophysics Reports
journal_nlm_ta: Biochem Biophys Rep
publisher_name: Elsevier
keywords: Autophagy | Metabolism | Cancer | Hypoxia | Starvation | Therapeutics
automl_pathway: 0.9576778
figid_alias: PMC8564564__F4
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8564564__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8564564__gr4.html
  '@type': Dataset
  description: Autophagy participating in tumor progression and tumor inhibition.
    1. Autophagy nurtures tumor progression by providing ATP to tumor cells. a. Autophagy
    directs glycolysis for ATP production. b. However, if glycolysis is not fully
    completed, it can be diverted to either glutaminolysis or pyruvate, and both can
    converge to the TCA cycle. c. Pyruvate can also be diverted to lactate and H+
    production in anaerobic conditions or acetyl CoA production in aerobic conditions.
    Further, acetyl CoA can either be directly involved in the TCA cycle or undergo
    Free fatty acids (FFA) production. d. FFA is simplified by entering β-oxidation
    and eventually converges to the TCA cycle. e. The activated TCA cycle with provided
    raw materials from different stages of metabolic pathways produces NADH and ATP,
    which fuels oxidative phosphorylation and gives rise to ATP production. f. The
    complex macromolecules are recycled by autophagy and produce ATPs. 2. Autophagy
    inhibits tumor progression. a. JNK1 phosphorylates and deactivates Bcl-2, whereas
    DAPK phosphorylates and activates BECN1, thereby disrupting the Bcl-2-BECN1 complex
    and releases BECN1. b. p53 upregulating either UVRAG or Bif-1 that form multiprotein
    complex BECN1. c. the activated BECN1 further complexes with VPS-34 and promotes
    autophagosome formation. d. p53 subcellular localization gives contrasting results
    as p53 inside the nucleus activates AMPK promoting autophagy whereas in cytoplasm
    promotes mTOR, which inhibits autophagy.e. Autophagy promotes tumor inhibition
    by preventing p62 (SQSTM1) accumulation, DNA damage and activating the pentose
    phosphate pathway. NADPH activates the enzymes glutathione and impedes ROS production.
    (Abbreviations- FFA-Free fatty acids, JNK1- c Jun N Terminal Kinase, DAPK-Death
    Associated Protein Kinase, UVRAG-UV radiation resistance-associated gene, Bif-1-Bax-interacting
    factor-1, AMPK- AMP-Activated Protein Kinase, the mTOR-mechanistic target of rapamycin).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Coa
  - ATPsynbeta
  - Atpalpha
  - p53
  - betaTub60D
  - hth
  - Uvrag
  - Mtor
  - Tor
  - Debcl
  - Atg6
  - Pi3K59F
  - SNF4Agamma
  - AMPKalpha
  - ref(2)P
  - DCTN4-p62
  - Tfb1
  - Nup62
  - Taf6
  - how
  - ATP8A2
  - TP53
  - TP63
  - TP73
  - UVRAG
  - SH3GLB1
  - MTOR
  - BCL2
  - BECN1
  - PIK3C3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAPK9
  - DAPK1
  - DAPK2
  - DAPK3
  - STK17A
  - STK17B
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - DECR1
---
